University of Cologne: STOP PKD - Study Investigates Treatment Option for People With the Most Common Form of Genetic Kidney Disease
December 11, 2025
December 11, 2025
KOLN, Germany, Dec. 11 -- The University of Cologne issued the following news release:
* * *
STOP PKD - Study investigates a new treatment option for people with the most common form of genetic kidney disease
Scientists have initiated a study to investigate whether dapagliflozin, an already approved drug from the SGLT2 inhibitors group, can positively affect the course of autosomal dominant polycystic kidney disease (ADPKD)
*
For . . .
* * *
STOP PKD - Study investigates a new treatment option for people with the most common form of genetic kidney disease
Scientists have initiated a study to investigate whether dapagliflozin, an already approved drug from the SGLT2 inhibitors group, can positively affect the course of autosomal dominant polycystic kidney disease (ADPKD)
*
For . . .